These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31204286)

  • 21. Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides.
    Pitta E; Rogacki MK; Balabon O; Huss S; Cunningham F; Lopez-Roman EM; Joossens J; Augustyns K; Ballell L; Bates RH; Van der Veken P
    J Med Chem; 2016 Jul; 59(14):6709-28. PubMed ID: 27348630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads.
    Tanwar B; Kumar A; Yogeeswari P; Sriram D; Chakraborti AK
    Bioorg Med Chem Lett; 2016 Dec; 26(24):5960-5966. PubMed ID: 27839684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shortening the treatment of tuberculosis.
    Mitchison DA
    Nat Biotechnol; 2005 Feb; 23(2):187-8. PubMed ID: 15696148
    [No Abstract]   [Full Text] [Related]  

  • 24. Design, synthesis and evaluation of acridine and fused-quinoline derivatives as potential anti-tuberculosis agents.
    Muscia GC; Buldain GY; Asís SE
    Eur J Med Chem; 2014 Feb; 73():243-9. PubMed ID: 24412719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
    Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and biological evaluation of novel quinoline-based carboxylic hydrazides as anti-tubercular agents.
    Chander S; Ashok P; Cappoen D; Cos P; Murugesan S
    Chem Biol Drug Des; 2016 Oct; 88(4):585-91. PubMed ID: 27203404
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Quimque MTJ; Go AD; Lim JAK; Vidar WS; Macabeo APG
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diarylquinolines, synthesis pathways and quantitative structure--activity relationship studies leading to the discovery of TMC207.
    Guillemont J; Meyer C; Poncelet A; Bourdrez X; Andries K
    Future Med Chem; 2011 Sep; 3(11):1345-60. PubMed ID: 21879841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and in-vitro antimycobacterial evaluation of 1-(cyclopropyl/2,4-difluorophenyl/tert-butyl)-1,4-dihydro- 8-methyl-6-nitro-4-oxo-7-(substituted secondary amino)quinoline-3-carboxylic acids.
    Senthilkumar P; Dinakaran M; Chandraseakaran Y; Yogeeswari P; Sriram D
    Arch Pharm (Weinheim); 2009 Feb; 342(2):100-12. PubMed ID: 19137533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of 3-heteroarylthioquinoline derivatives and their in vitro antituberculosis and cytotoxicity studies.
    Chitra S; Paul N; Muthusubramanian S; Manisankar P; Yogeeswari P; Sriram D
    Eur J Med Chem; 2011 Oct; 46(10):4897-903. PubMed ID: 21855182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 4-Aminoquinoline derivatives as novel Mycobacterium tuberculosis GyrB inhibitors: Structural optimization, synthesis and biological evaluation.
    Medapi B; Suryadevara P; Renuka J; Sridevi JP; Yogeeswari P; Sriram D
    Eur J Med Chem; 2015 Oct; 103():1-16. PubMed ID: 26318054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of novel acetohydroxyacid synthase inhibitors as active agents against Mycobacterium tuberculosis by virtual screening and bioassay.
    Wang D; Zhu X; Cui C; Dong M; Jiang H; Li Z; Liu Z; Zhu W; Wang JG
    J Chem Inf Model; 2013 Feb; 53(2):343-53. PubMed ID: 23316686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lead identification and optimization of bacterial glutamate racemase inhibitors.
    Malapati P; Siva Krishna V; Nallangi R; Meda N; Reshma Srilakshmi R; Sriram D
    Bioorg Med Chem; 2018 Jan; 26(1):177-190. PubMed ID: 29239770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, biological evaluation and molecular modelling studies of novel quinoline derivatives against Mycobacterium tuberculosis.
    Upadhayaya RS; Vandavasi JK; Vasireddy NR; Sharma V; Dixit SS; Chattopadhyaya J
    Bioorg Med Chem; 2009 Apr; 17(7):2830-41. PubMed ID: 19285414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of novel quinoline-aminopiperidine hybrid analogues as Mycobacterium tuberculosis DNA gyraseB inhibitors.
    Medapi B; Renuka J; Saxena S; Sridevi JP; Medishetti R; Kulkarni P; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2015 May; 23(9):2062-78. PubMed ID: 25801151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benzimidazole-based compounds kill Mycobacterium tuberculosis.
    Gong Y; Somersan Karakaya S; Guo X; Zheng P; Gold B; Ma Y; Little D; Roberts J; Warrier T; Jiang X; Pingle M; Nathan CF; Liu G
    Eur J Med Chem; 2014 Mar; 75():336-53. PubMed ID: 24556148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quinoline and quinolones: promising scaffolds for future antimycobacterial agents.
    Singh S; Kaur G; Mangla V; Gupta MK
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):492-504. PubMed ID: 25032745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformationally-constrained indeno[2,1-c]quinolines--a new class of anti-mycobacterial agents.
    Upadhayaya RS; Lahore SV; Sayyed AY; Dixit SS; Shinde PD; Chattopadhyaya J
    Org Biomol Chem; 2010 May; 8(9):2180-97. PubMed ID: 20401395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The synthesis and in vitro biological evaluation of novel fluorinated tetrahydrobenzo[j]phenanthridine-7,12-diones against Mycobacterium tuberculosis.
    Cappoen D; Torfs E; Meiresonne T; Claes P; Semina E; Holvoet F; de Macedo MB; Cools F; Piller T; Matheeussen A; Van Calster K; Caljon G; Delputte P; Maes L; Neyrolles O; De Kimpe N; Mangelinckx S; Cos P
    Eur J Med Chem; 2019 Nov; 181():111549. PubMed ID: 31376569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.
    Naidu KM; Nagesh HN; Singh M; Sriram D; Yogeeswari P; Gowri Chandra Sekhar KV
    Eur J Med Chem; 2015 Mar; 92():415-26. PubMed ID: 25590862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.